Page last updated: 2024-11-05

ticlopidine and Conus Medullaris Syndrome

ticlopidine has been researched along with Conus Medullaris Syndrome in 2 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iskandar, MZ1
Chong, V1
Hutcheon, S1
Seet, RC1
Lim, EC1
Wilder-Smith, EP1
Ong, BK1

Other Studies

2 other studies available for ticlopidine and Conus Medullaris Syndrome

ArticleYear
Acute spinal cord compression: a rare complication of dual antiplatelet therapy.
    BMJ case reports, 2015, Jul-22, Volume: 2015

    Topics: Acute Disease; Aged; Aspirin; Clopidogrel; Drug Therapy, Combination; Fatal Outcome; Female; Hematom

2015
Spontaneous epidural haematoma presenting as cord compression in a patient receiving clopidogrel.
    European journal of neurology, 2005, Volume: 12, Issue:10

    Topics: Clopidogrel; Hematoma, Epidural, Spinal; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Plat

2005